Are you Dr. LeBoeuf?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
Mskcc, Endocrinology Service Box 332
New York, NY 10065Phone+1 646-888-2712Fax+1 646-888-2737
Summary
- Dr. Rebecca LeBoeuf, MD is an endocrinologist in New York, New York.
Clinical Trials
- Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer Start of enrollment: 2003 Sep 01
Publications & Presentations
PubMed
- 497 citationsSelumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid CancerAlan L. Ho, Ravinder K. Grewal, Rebecca Leboeuf, Eric J. Sherman, David G. Pfister
The New England Journal of Medicine. 2013-02-13 - 106 citationsBRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines.Rebecca Leboeuf, Jacqueline E. Baumgartner, Miriam Benezra, Roberta Malaguarnera, David B. Solit
The Journal of Clinical Endocrinology and Metabolism. 2008-06-01
